Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | PGK1 | P00558 | 1/20 | 0.32 |
| ▸ | PGK2 | P07205 | 1/20 | 0.32 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.32 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.30 |
| ▸ | TET3 | O43151 | 1/20 | 0.30 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17767400 | 0.83 | PAX8 (0.36) | PAX8 | |
| SCHEMBL17748583 | 0.81 | PAX8 (0.36) | USP2SLCO1B1PAX8 | |
| SCHEMBL17748555 | 0.81 | PAX8 (0.34) | PAX8 | |
| SCHEMBL5355000 | 0.81 | PAX8 (0.37) | USP2SLCO1B1PAX8 | |
| SCHEMBL20889 | 0.80 | PAX8 (0.36) | USP2SLCO1B1PAX8 | |
| SCHEMBL9807659 | 0.80 | PAX8 (0.36) | USP2SLCO1B1PAX8 | |
| SCHEMBL1775575 | 0.80 | SMN1; SMN2 (0.34) | SMN1; SMN2PAX8 | |
| SCHEMBL722958 | 0.80 | PAX8 (0.32) | PAX8 | |
| SCHEMBL7217304 | 0.79 | PDE4A (0.47) | SMN1; SMN2USP2PGK1PGK2SLCO1B1 | |
| SCHEMBL721030 | 0.78 | TSHR (0.36) | PAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7943598-B2 | Use of organic glucosamine salts | BIOIBERICA, S.A. (ES) | 2011-05-17 | — | — | US | claimed |
| EP-1781304-B1 | USE OF ORGANIC GLUCOSAMINE SALTS | BIOIBERICA (ES) | 2009-09-09 | — | — | EP | claimed |
| US-20070244070-A1 | Use of Organic Glucosamine Salts | BIOIBERICA, S.A. (ES) | 2007-10-18 | — | — | US | claimed |
| EP-1781304-A1 | USE OF ORGANIC GLUCOSAMINE SALTS | BIOIBERICA, S.A. (ES) | 2007-05-09 | — | — | EP | claimed |
| WO-2006012951-A1 | USE OF ORGANIC GLUCOSAMINE SALTS | BIOIBERICA, S.A. (ES) | 2006-02-09 | — | — | WO | claimed |
| US-7943598-B2 | Use of organic glucosamine salts | BIOIBERICA, S.A. (ES) | 2011-05-17 | — | — | US | disclosed |
| US-7943598-B2 | Use of organic glucosamine salts | BIOIBERICA, S.A. (ES) | 2011-05-17 | — | — | US | disclosed |
| EP-1781304-B1 | USE OF ORGANIC GLUCOSAMINE SALTS | BIOIBERICA (ES) | 2009-09-09 | — | — | EP | disclosed |
| EP-1781304-B1 | USE OF ORGANIC GLUCOSAMINE SALTS | BIOIBERICA (ES) | 2009-09-09 | — | — | EP | disclosed |
| US-20070244070-A1 | Use of Organic Glucosamine Salts | BIOIBERICA, S.A. (ES) | 2007-10-18 | — | — | US | disclosed |
| US-20070244070-A1 | Use of Organic Glucosamine Salts | BIOIBERICA, S.A. (ES) | 2007-10-18 | — | — | US | disclosed |
| EP-1781304-A1 | USE OF ORGANIC GLUCOSAMINE SALTS | BIOIBERICA, S.A. (ES) | 2007-05-09 | — | — | EP | disclosed |
| EP-1781304-A1 | USE OF ORGANIC GLUCOSAMINE SALTS | BIOIBERICA, S.A. (ES) | 2007-05-09 | — | — | EP | disclosed |
| WO-2006012951-A1 | USE OF ORGANIC GLUCOSAMINE SALTS | BIOIBERICA, S.A. (ES) | 2006-02-09 | — | — | WO | disclosed |
| WO-2006012951-A1 | USE OF ORGANIC GLUCOSAMINE SALTS | BIOIBERICA, S.A. (ES) | 2006-02-09 | — | — | WO | disclosed |